Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

ForHumanity™ Launches VigorAir™: The Only Doctor-Prescribed ED Treatment Powered by Breath

ForHumanity

News provided by

ForHumanity

Oct 27, 2025, 11:57 ET

Share this article

Share toX

Share this article

Share toX

Innovative telehealth startup introduces inhalable ED and migraine relief plus a gut-friendly metformin gummy for blood sugar and longevity

SAN DIEGO, Oct. 27, 2025 /PRNewswire/ -- ForHumanity Health Inc. today announced its public launch, introducing the only doctor-prescribed erectile dysfunction (ED) treatment powered by breath — VigorAir™, a dry-powder inhaler formulation of sildenafil (the active ingredient in Viagra®) delivered via a breath-activated inhaler and designed to reach the bloodstream through the lungs—without relying on digestion.

ForHumanity's proprietary technology transforms raw materials into precision-engineered therapeutic products. Unlike traditional pills that can take an hour or more to act, and often cause stomach upset, ForHumanity's micro-encapsulation technology enables nominal doses designed for rapid uptake that are more gut-friendly since they don't rely on digestion. The result: a smarter, more human way to manage health.

The company is also unveiling MetaChew™, a gut-friendly metformin gummy designed to improve adherence by reducing GI side effects, and ZapMigraine™, an inhalable dry-powder inhalation treatment for rapid migraine relief.

A $100 BILLION CHALLENGE

For decades, patients have been stuck with prescribed high-dose oral medications that can stress the gut, delay relief, and cause unnecessary side effects. That's a broken model for:

  • 30M men with erectile dysfunction — 34% abandon pills due to slow onset and side effects (National Institutes of Health).
  • 96M Americans with prediabetes — plus millions using metformin for longevity. GI side effects are common, affecting up to 25% of patients, and about 5% discontinue therapy entirely due to intolerance (Centers for Disease Control and Prevention).
  • 39M migraine sufferers — 95% cite unmet needs for faster, more reliable relief (American Migraine Foundation).

THE APPROACH: NOVEL DELIVERY SYSTEMS

ForHumanity's launch sequence flips this paradigm with first-in-class delivery systems:

  • VigorAir™ (Debut Offering): An inhalable alternative to traditional ED medication, and the same active ingredient in Viagra®, backed by decades of clinical efficacy. A discreet, propellant-free inhaler designed to deliver results directly into the bloodstream via the lungs without relying on digestion, restoring intimacy without the wait.
  • MetaChew™ (Fall/Winter 2025): Among the first U.S. doctor-prescribed metformin gummy options, featuring ForHumanity's pioneering microencapsulation coating, designed to bypass the stomach and reduce GI side effects. Metformin is not only the second most prescribed drug in the U.S.; it is also increasingly used off-label for longevity, weight management and metabolic optimization.
  • ZapMigraine™ (Fall/Winter 2025): Among the first doctor-prescribed, dry-powder inhaled migraine options in the U.S, designed for rapid pulmonary uptake through the lungs that does not rely on digestion.

"This is the future of medicine —more convenient routes and right‑sized nominal doses where appropriate, delivered in ways that fit patients' lives," added Dr. Eva Selhub, Chief of Medical Affairs. "I'm thrilled to be part of the team that is creating new delivery methods so patients are more resilient and in tune with their health."

A TRUE PLATFORM FOR THE FUTURE OF HEALTH AND WELLBEING

ForHumanity is building a precision health platform. Every therapy will be paired with premium organic supplements and physician-prescribed peptides to create integrated health "stacks" that treat acute symptoms while supporting long-term resilience.

"Patients are tired of waiting an hour for a pill to kick in or dealing with side effects they don't need," said James Messer, CEO and Co-Founder. "With ForHumanity, you can take control of your health on your terms, when timing matters. Our technology isn't just about making medication easier to take. It's about unlocking a new layer of control over how our bodies perform and heal, and making biohacking more accessible to as many people as possible."

ForHumanity is built with trust and privacy at its core: the process is fully HIPAA-compliant, ensuring that all patient data is safeguarded to the highest medical privacy standards. ForHumanity also works with Freshpaint to carefully manage tracking and analytics, ensuring that no sensitive or personally identifiable health data is ever sent to third parties.

ACCESS MADE SIMPLE

Patients start with a quick online health profile and consult with a licensed healthcare provider on their telehealth site at forhumanity.co. If treatment is right for them and prescribed, memberships are designed to fit your lifestyle—whether you need occasional support or ongoing, everyday care—with continuous access to licensed healthcare providers to keep you on track. Memberships for VigorAir™ start at $10.99 per dose, while MetaChew™ and ZapMigraine™ plan options will be available later this year. All ForHumanity products are shipped in discreet packaging with free two-day delivery in the U.S.

WHAT'S NEXT

As people continue to focus on the best ways to manage their own wellbeing and the benefits of biohacking, ForHumanity will be there as a trusted partner and resource across their healthcare journey and lifestyle transformation. ForHumanity's roadmap extends beyond ED, metabolic health, and migraine relief, and future launches will continue to offer products that optimize people's health and wellbeing journeys — all delivered through innovative inhalers, gut-friendly formulations, and premium supplements paired with physician-prescribed peptides.

For more information, visit forhumanity.co.

About ForHumanity:
Launched in 2025, ForHumanity Health Inc. is a telehealth company focused on building a future where healthcare feels human again. Our mission is simple: to deliver holistic, high-impact care by integrating personalized medicine, nutraceuticals, and community-based support. We're redefining how medicine works—at the molecular level. Through cutting-edge, patented micro-encapsulation technology, we deliver precision therapies exactly where they're needed—fast, efficient, and reliable.

SOURCE ForHumanity

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.